Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

31.8K
This manuscript describes the use of nasal and bronchial absorption techniques, specifically using synthetic absorptive matrices (SAM) to sample the mucosal lining fluid (MLF) of the upper and lower airway. These methods provide better standardization and tolerability than existing respiratory sampling...
31.8K
Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

7.6K
Recombinant prototype foamy virus integrase protein is often contaminated with a bacterial nuclease during purification. This method identifies nuclease contamination and removes it from the final preparation of the...
7.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

8.3K
Human respiratory syncytial virus (HRSV) can cause severe bronchiolitis in young infants. Part of the pathogenesis of severe HRSV disease is caused by the host immune response. Stimulation of primary human immune cells with HRSV provides a fast and reproducible model system to study activation of inflammatory pathways and...
8.3K
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

8.6K
Routine detection methods utilizing viral genome amplification are limited by their inability to discriminate infectious from non-infectious particles. The purpose of this article is to provide detailed protocols for alternative methods to aid in discrimination of infectious norovirus particles using aptamer binding, dynamic light scattering, and transmission electron...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.

Infection·2021
Same author

[Dyspnoea and Comorbidity in Lung Cancer-Patients: The Therapy Starts with Taking the Patients History].

Pneumologie (Stuttgart, Germany)·2021
Same author

[New and rare pneumotropic viruses].

Der Pneumologe·2020
Same author

[Community-acquired Pneumonia in the Elderly].

Pneumologie (Stuttgart, Germany)·2019
Same author

[Community-acquired Pneumonia in the Elderly].

Pneumologie (Stuttgart, Germany)·2019
Same author

[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa].

Pneumologie (Stuttgart, Germany)·2018
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

31.8K

[Rhinoviruses].

A Grünewaldt1, C Hügel1, G G U Rohde2

  • 1Pneumologie/Allergologie, Medizinische Klinik 1, Universitätsklinikum Frankfurt, Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland.

Der Internist
|August 30, 2019
PubMed
Summary
This summary is machine-generated.

Human rhinoviruses cause the common cold and worsen chronic lung diseases. Current diagnostic and therapeutic strategies are limited, presenting a significant challenge for public health.

Keywords:
Antiviral agentsDisease exacerbation, viralPicornaviridaePneumoniaRespiratory tract infection

More Related Videos

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

7.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

Related Experiment Videos

Last Updated: Jan 20, 2026

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

31.8K
Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
07:50

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase

Published on: December 8, 2017

7.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

Area of Science:

  • Virology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Human rhinoviruses (RV), part of the Picornaviridae family, are classified into three species: A, B, and C.
  • RV are the primary cause of upper respiratory tract infections (common cold) and hold significant epidemiological and clinical importance.
  • These viruses are implicated in acute exacerbations of chronic airway diseases like asthma and COPD, with ongoing research into their role in pneumonia and critical illness.

Purpose of the Study:

  • To highlight the clinical and epidemiological significance of human rhinoviruses.
  • To underscore the diagnostic challenges associated with rhinovirus infections.
  • To emphasize the lack of specific antiviral therapies and vaccine development hurdles due to viral diversity.

Main Methods:

  • Review of current literature on human rhinovirus (RV) epidemiology, clinical impact, diagnosis, and treatment.
  • Analysis of diagnostic difficulties, including distinguishing infection from contamination.
  • Examination of challenges in developing antiviral strategies and vaccines.

Main Results:

  • Human rhinoviruses (RV) are major causes of the common cold and exacerbate chronic respiratory conditions.
  • Diagnosis is complicated by non-specific symptoms and sophisticated laboratory detection methods.
  • Effective antiviral treatments and vaccines are currently unavailable due to the vast diversity of RV subtypes.

Conclusions:

  • Human rhinoviruses (RV) represent a significant public health concern due to their widespread impact on respiratory health.
  • The development of effective diagnostic tools and targeted therapies for RV infections remains a critical unmet need.
  • Overcoming the challenge of RV subtype diversity is essential for future vaccine development.